The Use of Magnesium Sulphate for the Treatment of Severe Pre-Eclampsia and Eclampsia
Ann. afr. med
; 8(2): 76-80, 2009.
Article
in English
| AIM
| ID: biblio-1259013
Responsible library:
CG1.1
ABSTRACT
Background:
Pre-eclampsia and eclampsia are important causes of maternal and perinatal morbidity and mortality in the developing countries. There is need to provide the most effective management to pre-eclamptic and eclamptic patients. There is now evidence that magnesium sulphate is the most effective anticonvulsant.Method:
In this article; a literature review was made on the contribution of pre-eclampsia and eclampsia to maternal mortality and how it can be curtailed by the use of magnesium sulphate.Results:
The drug is administered by the Pritchard or Zuspan regimen; although modifications in the two protocols have been reported.Conclusion:
A Nigerian national protocol has been developed on its use. There is need for further training of health workers on how to use this important drug
Full text:
Available
Index:
AIM (Africa)
Main subject:
Pre-Eclampsia
/
Maternal Mortality
/
Eclampsia
/
Magnesium
Language:
English
Journal:
Ann. afr. med
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS